Eyepoint Inc 's Cash & cash equivalent grew by 16.93 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Eyepoint Inc 's Quick Ratio to 7.8, above Eyepoint Inc average Quick Ratio.

Within Laboratory Analytical Instruments industry 2 other companies have achieved higher Quick Ratio than Eyepoint Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 506, from total ranking in the first quarter 2026 at 527.

Explain Quick Ratio?
How much Cash & cash equivalents EYPT�s has?
What are EYPT�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/EYPT/financial-strength

https://api.csimarket.com/api/v1/companies/EYPT/fundamentals

https://api.csimarket.com/api/v1/companies/EYPT/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

EYPT Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	26.43 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	3.31 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	7.8	Subscribe	Subscribe	Subscribe	Subscribe
EYPT's Total Ranking	# 506	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	11.97 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	16.93 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 3
Healthcare Sector	# 211
Overall Market	# 506

Quick Ratio Statistics
High	Average	Low
13.94	5.83	1.25
(Dec 31 2014)		(Mar 31 2018)

Financial Statements
Eyepoint Inc 's Current Liabilities	$ 42 Millions	Visit EYPT's Balance sheet
Eyepoint Inc 's Cash & cash equivalent	$ 327 Millions	Visit EYPT's Balance sheet
Source of EYPT's Sales		Visit EYPT's Sales by Geography

Cumulative Eyepoint Inc 's Quick Ratio

EYPT's Quick Ratio for the trailling 12 Months

EYPT Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-15.16 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-11.8 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	8.64	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 3475	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	6.37 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	0.84 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to EYPT Financial Strength Comparisons >> Go to Compare EYPT Quick Ratio to its Competitors

On the trailing twelve months basis Due to increase in Current Liabilities in the Q2 2026 to $41.94 millions, cumulative Quick Ratio decreased to 8.64 above the EYPT average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 21 other companies have achieved higher Quick Ratio than Eyepoint Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 2583 to 3475.

Explain Quick Ratio?
How much Cash & cash equivalents EYPT�s has?
What are EYPT�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Laboratory Analytical Instruments Industry	# 22
Healthcare Sector	# 856
Within the Market	# 3475

trailing twelve months Quick Ratio Statistics
High	Average	Low
12.15	6.03	2.05
(Sep 30 2015)		(Mar 31 2018)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Laboratory Analytical Instruments Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Alamar Biosciences Inc	8.94	$ 250.052 Millions	$ 27.960 Millions
Eyepoint Inc	7.80	$ 327.214 Millions	$ 41.943 Millions
Pacific Biosciences Of California Inc	5.74	$ 236.873 Millions	$ 41.294 Millions
Astrotech Corp	5.02	$ 11.334 Millions	$ 2.257 Millions
Scientific Industries Inc	4.92	$ 7.882 Millions	$ 1.602 Millions
Standard Biotools Inc	4.75	$ 270.026 Millions	$ 56.802 Millions
10x Genomics Inc	4.66	$ 552.058 Millions	$ 118.509 Millions
Cytek Biosciences Inc	2.83	$ 262.004 Millions	$ 92.698 Millions
Quanterix Corporation	1.86	$ 93.529 Millions	$ 50.373 Millions

Date modified: 2026-10-15T05:23:37+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.